Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia

Author： Bitter I.   Dossenbach M.R.K.   Brook S.   Feldman P.D.   Metcalfe S.   Gagiano C.A.   Furedi J.   Bartko G.   Janka Z.   Banki C.M.   Kovacs G.   Breier A.   for the Olanzapine HGCK Study Group  

Publisher： Elsevier

ISSN： 0278-5846

Source： Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol.28, Iss.1, 2004-01, pp. : 173-180

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Aripiprazole Augmentation of Clozapine in Treatment-Resistant Schizophrenia: A Clinical Observation

By Ziegenbein Marc  

Clinical Drug Investigation, Vol. 26, Iss. 3, 2006-01 ,pp. : 117-124

Adis International

Access to resources Recommend Favorite

Despite safety concerns, clozapine has a unique profile of clinical benefits in patients with treatment-resistant schizophrenia or schizophrenia-associated suicidality

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 10, 2007-10 ,pp. : 9-13

Adis International

Access to resources Recommend Favorite

Ziprasidone effective in treatment-resistant schizophrenia

By  

Inpharma, Vol. 1, Iss. 1522, 2006-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Olanzapine pamoate for the treatment of schizophrenia

By Naber Dieter  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 4, 2011-03 ,pp. : 627-633

Informa Healthcare

Access to resources Recommend Favorite

Treatment-resistant schizophrenia: clinical experience with new antipsychotics

By Dufour H.   Bondolfi G.   Baumann P.   Seywert F.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 202-202

Elsevier

Access to resources Recommend Favorite